991
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia

ORCID Icon, , , , , , , , , , & ORCID Icon show all
Article: 2317268 | Received 21 Nov 2023, Accepted 30 Jan 2024, Published online: 12 Mar 2024

References

  • Cagnacci A, Venier M, Xholli A, et al. Female sexuality and vaginal health across the menopausal age. Menopause. 2020;27(1):1–6. PMID: 31738734. doi: 10.1097/GME.0000000000001427.
  • Goncharenko V, Bubnov R, Polivka J, Jr, et al. Vaginal dryness: ndividualized patient profiles, risks and mitigating measures. Epma J. 2019;10(1):73–79. PMID: 30984316; PMCID: PMC6459457. doi: 10.1007/s13167-019-00164-3.
  • Vaginal dryness [Internet]. Women’s health concern. Available from: https://www.womens-health-concern.org/wp-content/uploads/2023/11/25-WHC-FACTSHEET-VaginalDryness-OCT2023-B.pdf.
  • Hill DA, Taylor CA. Dyspareunia in women. Am Fam Physician. 2021;103(10):597–604. PMID: 33983001.
  • De Graaff AA, Van Lankveld J, Smits LJ, et al. Dyspareunia and depressive symptoms are associated with impaired sexual functioning in women with endometriosis, whereas sexual functioning in their male partners is not affected. Hum Reprod. 2016;31(11):2577–2586. Epub 2016 Sep 12. PMID: 27619771. doi: 10.1093/humrep/dew215.
  • Sorensen J, Bautsita K, Lamvu G, et al. Evaluation and treatment of female sexual pain: a clinical review. Cureus. 2018;10(3):e2379. PMID: 29805948; PMCID: PMC5969816. doi: 10.7759/cureus.2379.
  • Tommola P, Unkila-Kallio L, Paavonen J. Surgical treatment of vulvar vestibulitis: a review. Acta Obstet Gynecol Scand. 2010; 89(11):1385–1395. PMID: 20955094. doi: 10.3109/00016349.2010.512071.
  • Da Silva AS, Baines G, Araklitis G, et al. Modern management of genitourinary syndrome of menopause. Fac Rev. 2021;10:25. PMID: 33718942; PMCID: PMC7946389. doi: 10.12703/r/10-25.
  • Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021; 24(1):19–24. Epub 2020 Sep 29. PMID: 32990054. doi: 10.1080/13697137.2020.1820478.
  • Schiavi MC, Di Tucci C, Colagiovanni V, et al. A medical device containing purified bovine colostrum (monurelle biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: retrospective analysis of urinary symptoms, sexual function, and quality of life. Low Urin Tract Symptoms. 2019;11(2):O11–O15. doi: 10.1111/luts.12204.Epub 2017 Oct 23. PMID: 29057583.
  • Kennedy CE, Yeh PT, Li J, et al. Lubricants for the promotion of sexual health and well-being: a systematic review. Sex Reprod Heal Matters. 2021;29(3):2044198.
  • Sutton KS, Boyer SC, Goldfinger C, et al. To lube or not to lube: experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med. 2012;9(1):240–250. Jan doi: 10.1111/j.1743-6109.2011.02543.x.
  • Palacios S, Hood S, Abakah-Phillips T, et al. A randomized trial on the effectiveness and safety of 5 water-based personal lubricants. J Sex Med. 2023;20(4):498–506. PMID: 36781402. doi: 10.1093/jsxmed/qdad005.
  • Sarmento ACA, Kamilos MF, Costa APF, et al. Use of moisturizers and lubricants for vulvovaginal atrophy. Front Reprod Health. 2021;3:781353. PMID: 36303977; PMCID: PMC9580673. doi: 10.3389/frph.2021.781353.
  • Nappi RE, Martella S, Albani F, et al. Hyaluronic acid: a valid therapeutic option for early management of genitourinary syndrome of menopause in cancer survivors? Healthcare (Basel). 2022;10(8):1528. PMID: 36011183; PMCID: PMC9408661. doi: 10.3390/healthcare10081528.
  • Alvisi S, Gava G, Orsili I, et al. Vaginal health in menopausal women. Medicina (Kaunas). 2019;55(10):615. PMID: 31547180; PMCID: PMC6843679. doi: 10.3390/medicina55100615.
  • Buzzaccarini G, Marin L, Noventa M, et al. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021;24(6):560–571. Epub 2021 Mar 24. PMID: 33759670. doi: 10.1080/13697137.2021.1898580.
  • Stute P. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? Arch Gynecol Obstet. 2013; 288(6):1199–1201. PMID: 24178484. doi: 10.1007/s00404-013-3068-5.
  • Potekaev NN, Borzykh OB, Medvedev GV, et al. The role of extracellular matrix in skin wound healing. J Clin Med. 2021;10(24):5947. PMID: 34945243; PMCID: PMC8706213. doi: 10.3390/jcm10245947.
  • Dos Santos CCM, Uggioni MLR, Colonetti T, et al. Hyaluronic acid in postmenopause vaginal atrophy: a systematic review. J Sex Med. 2021;18(1):156–166. Epub 2020 Dec 5. PMID: 33293236. doi: 10.1016/j.jsxm.2020.10.016.
  • González-Isaza P, Sánchez-Prieto M, Sánchez-Borrego R. Chronic vulvar fissure: approach with cross-linked hyaluronic acid. Int Urogynecol J. 2023;34(7):1495–1499. Epub 2022 Nov 7. PMID: 36344691. doi: 10.1007/s00192-022-05401-4.
  • World Health Organization. Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI360: advisory note. World Health Organization; 2012. https://apps.who.int/iris/handle/10665/76580.
  • Mieza Arana JA, Cortés Ceballos R, Blasco Zapater P, et al. Clinical study of hyaluronic acid gel in dyspareunia caused by vaginal dryness. Prog Obstet Ginecol. 2018;61(4):341–344. doi: 10.20960/j.pog.00111.
  • Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.
  • Meston CM, Freihart BK, Handy AB, et al. Scoring and interpretation of the FSFI: What can be learned from 20 years of use? J Sex Med. 2020;17(1):17–25. doi: 10.1016/j.jsxm.2019.10.007.
  • Sánchez-Sánchez B, Navarro-Brazález B, Arranz-Martín B, et al. The female sexual function index: transculturally adaptation and psychometric validation in Spanish women. Int J Environ Res Public Health. 2020;17(3):994. Feb 5 Erratum in: int J Environ Res Public Health. 2020 Jun 17;17(12): PMID: 32033334; PMCID: PMC7037847. doi: 10.3390/ijerph17030994.
  • Webber CM, Caldwell B, Bocell FD, et al. Patient-reported outcomes and medical device evaluation: from conception to implementation. J Patient Rep Outcomes. 2022;6(1):53. PMID: 35608682; PMCID: PMC9127472. doi: 10.1186/s41687-022-00463-w.
  • Chen J, Geng L, Song X, et al. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575–1584. Epub 2013 Apr 9. PMID: 23574713. doi: 10.1111/jsm.12125.
  • Karaosmanoglu O, Cogendez E, Sozen H, et al. Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis. Int J Gynaecol Obstet. 2011;113(2):156–157. Epub 2011 Mar 21. PMID: 21420087. doi: 10.1016/j.ijgo.2010.12.007.
  • Morali G, Polatti F, Metelitsa EN, et al. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung. 2011;56(03):230–238. PMID: 16618016. doi: 10.1055/s-0031-1296715.
  • Caruso S, Bruno MT, Boemi S, et al. Vaginal health and quality of sexual life of postmenopausal women on hyaluronic acid and biosaccharide gum-1 vaginal gel. Taiwan J Obstet Gynecol. 2023;62(5):702–708. PMID: 37678998. doi: 10.1016/j.tjog.2023.07.011.
  • Terauchi M, Odai T, Kato K, et al. Body weight and body fat are negatively associated with severe dyspareunia in postmenopausal women. J of Obstet and Gynaecol. 2022;48(12):3279–3285. Epub 2022 Sep 6. PMID: 36065957. doi: 10.1111/jog.15418.
  • Maserejian NN, Shifren J, Parish SJ, et al. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther. 2012;38(1):41–62. PMID: 22268981. doi: 10.1080/0092623X.2011.569642.
  • Feldhaus-Dahir M. The physiology and causes of female sexual arousal disorder: part I. Urol Nurs. 2009; 29(6):440–443. PMID: 20088237.
  • Scavello I, Maseroli E, Di Stasi V, et al. Sexual health in menopause. Medicina (Kaunas). 2019;55(9):559. PMID: 31480774; PMCID: PMC6780739. doi: 10.3390/medicina55090559.
  • Eden KJ, Wylie KR. Quality of sexual life and menopause. Womens Health (Lond Engl). 2009; 5(4):385–396. PMID: 19586430. doi: 10.2217/WHE.09.24.
  • Rosen RC, Althof SE, Barbach LG, et al. Female sexual well-being scale: responsiveness to interventional product use by sexually functional women. J Sex Med. 2010;7(7):2479–2486. Epub 2010 Apr 26. PMID: 20456627. doi: 10.1111/j.1743-6109.2010.01834.x.
  • Bosak Z, Iravani M, Moghimipour E, et al. Effect of chamomile vaginal gel on the sexual function in postmenopausal women: a Double-Blind randomized controlled trial. J Sex Med. 2022;19(6):983–994. PMID: 37057581. doi: 10.1016/j.jsxm.2022.03.536.
  • Suresh K. An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011; 4(1):8–11. Retraction in: J Hum Reprod Sci. 2023 Jan-Mar;16(1):87. PMID: 21772732; PMCID: PMC3136079. doi: 10.4103/0974-1208.82352.
  • Derogatis LR, Rosen R, Leiblum S, et al. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28(4):317–330. PMID: 12082670. doi: 10.1080/00926230290001448.
  • Monaghan TF, Agudelo CW, Rahman SN, et al. Blinding in clinical trials: seeing the big picture. Medicina (Kaunas). 2021; 57(7):647. PMID: 34202486; PMCID: PMC8308085. doi: 10.3390/medicina57070647.